Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 9/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.57 |
| ▸ | F7 | P08709 | 9/20 | 0.57 |
| ▸ | F10 | P00742 | 8/20 | 0.57 |
| ▸ | MRGPRX4 | Q96LA9 | 8/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.47 |
| ▸ | F3 | P13726 | 2/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7150884 | 0.94 | F2 (0.61) | F2PRSS1F7F10PRSS2 | |
| SCHEMBL7143415 | 0.91 | F2 (0.70) | F2PRSS1F7F10MRGPRX4 | |
| Acetic Acid SCHEMBL8128031 | 0.90 | F2 (0.68) | F2PRSS1F7F10MRGPRX4 | |
| SCHEMBL5882826 | 0.89 | MRGPRX4 (0.49) | F2PRSS1F7F10MRGPRX4 | |
| SCHEMBL7150630 | 0.88 | F2 (0.55) | F2PRSS1F7F10PRSS2 | |
| SCHEMBL7145663 | 0.86 | F2 (0.52) | F2PRSS1F7F10MRGPRX4 | |
| SCHEMBL8122404 | 0.86 | F2 (0.54) | F2PRSS1F7F10PRSS2 | |
| SCHEMBL7147573 | 0.84 | F2 (0.74) | F2PRSS1F7F10PRSS2 | |
| SCHEMBL7143873 | 0.84 | F2 (0.60) | F2PRSS1F7F10PRSS2 | |
| SCHEMBL8122456 | 0.84 | F2 (0.61) | F2PRSS1F7F10PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0921116-B1 | N-(4-carbamimido-phenyl)-glycine amide derivatives | HOFFMANN LA ROCHE (CH) | 2003-06-18 | — | — | EP | disclosed |
| US-6140353-A | USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 2000-10-31 | — | — | US | disclosed |
| EP-0921116-A1 | N-(4-carbamimido-phenyl)-glycine amide derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1999-06-09 | — | — | EP | disclosed |